Assignee
BRISTOL MYERS SQUIBB PHARMA CO
235 granted patents·19 pending applications·5,282 citations·filing 1997–2009
Top patents by PatentIndex Score
254 records- 0198US7183282B2Substituted heterocycle fused γ-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Feb 27, 2007·145 cites·4 claims
- 0298US6552017B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 22, 2003·208 cites·21 claims
- 0397US7344702B2Contrast agents for myocardial perfusion imagingBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Granted Mar 18, 2008·35 cites·1 claims
- 0497USRE39680ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·142 cites·21 claims
- 0597USRE39679ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·129 cites·33 claims
- 0697US7071186B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jul 4, 2006·121 cites·15 claims
- 0797US6998107B2Composition comprising low density microspheresBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Feb 14, 2006·48 cites·9 claims
- 0897US6989391B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 24, 2006·59 cites·35 claims
- 0997US6713471B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 30, 2004·172 cites·33 claims
- 1097US6548525B2Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 15, 2003·125 cites·17 claims
- 1197US6548493B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 15, 2003·179 cites·23 claims
- 1297US6403632B1Lactam metalloprotease inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jun 11, 2002·78 cites·18 claims
- 1396US6967208B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 22, 2005·100 cites·103 claims
- 1496US6699852B2Substituted pyridoindoles as serotonin agonists and antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Mar 2, 2004·130 cites·20 claims
- 1596US6548512B1Nitrogen containing heteroaromatics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 15, 2003·75 cites·52 claims
- 1695US7456278B2Lactams substituted by cyclic succinates as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Nov 25, 2008·13 cites·20 claims
- 1795US7342008B2Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Mar 11, 2008·15 cites·30 claims
- 1895US6939854B2Peptide inhibitors of hepatitis C virus NS3 proteaseBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Sep 6, 2005·65 cites·3 claims
- 1995US6727366B2Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 27, 2004·87 cites·4 claims
- 2095US6589958B1Isoxazolo [4,5-d] pyrimidines as CRF antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Jul 8, 2003·78 cites·4 claims
- 2195US6541639B2Efficient ligand-mediated Ullmann coupling of anilines and azolesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 1, 2003·92 cites·29 claims
- 2295US6537520B1Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 25, 2003·91 cites·37 claims
- 2395US6525069B1N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 25, 2003·52 cites·28 claims
- 2494US7423033B2Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2008·Granted Sep 9, 2008·13 cites·32 claims
- 2594US6998408B26-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 14, 2006·68 cites·30 claims
- 2694US6858626B2Cyclic hydroxamic acid as metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 22, 2005·66 cites·20 claims
- 2794US6500855B1Thrombin or factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Dec 31, 2002·40 cites·16 claims
- 2893US7498324B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Mar 3, 2009·18 cites·39 claims
- 2993US7456172B2Succinoylamino benzodiazepines as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Nov 25, 2008·19 cites·38 claims
- 3093US7390896B2Cyclic malonamides as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Jun 24, 2008·17 cites·27 claims
- 3193US6995172B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Feb 7, 2006·19 cites·9 claims
- 3293US6800273B2Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Oct 5, 2004·46 cites·25 claims
- 3393US6448261B1Arylamino fused pyridinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Sep 10, 2002·55 cites·9 claims
- 3492US7718795B2Succinoylamino benzodiazepines as inhibitors of aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2008·Granted May 18, 2010·13 cites·38 claims
- 3592US7528249B2Cyclic malonamides as inhibitors of aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2008·Granted May 5, 2009·13 cites·13 claims
- 3692US7390802B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Jun 24, 2008·17 cites·36 claims
- 3792US7276496B2Cyclic malonamides as inhibitors of Aβ protein protectionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Oct 2, 2007·13 cites·20 claims
- 3892US7005435B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Feb 28, 2006·19 cites·9 claims
- 3992US6960595B25-6 to 5-7 Heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 1, 2005·38 cites·35 claims
- 4092US6776977B2Polypodal chelants for metallopharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Aug 17, 2004·36 cites·3 claims
- 4192US6706712B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Mar 16, 2004·57 cites·29 claims
- 4292US6689770B2Aryl sulfonyls as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 10, 2004·29 cites·18 claims
- 4391US7655647B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2009·Granted Feb 2, 2010·13 cites·8 claims
- 4491US7304049B2Succinoylaminobenzodiazepines as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Granted Dec 4, 2007·13 cites·36 claims
- 4591US7101870B2Succinoylamino lactams as inhibitors of A-β protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Granted Sep 5, 2006·13 cites·44 claims
- 4691US6994852B1Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5BRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 7, 2006·23 cites·18 claims
- 4791US6958329B2Lactams substituted by cyclic succinates as inhibitors of A-β protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Oct 25, 2005·20 cites·72 claims
- 4891US6759411B2Heterocyclic piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jul 6, 2004·26 cites·45 claims
- 4991US6710058B2Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Mar 23, 2004·28 cites·23 claims
- 5091US6673810B2Imidazo-heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 6, 2004·43 cites·21 claims
Showing the top 50 of 254 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when BRISTOL MYERS SQUIBB PHARMA CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →